HDAC8 and neuroblastoma: Furthermore, inhibiting HDAC8 with selective HDAC8 inhibitors or siRNA-mediated knockdown reduces cell proliferation in cultured neuroblastoma cell lines and in vivo using xenograft mouse models [9].